Industries > Pharma > Vaccine Contract Manufacturing Market Report 2022-2032
Vaccine Contract Manufacturing Market Report 2022-2032
Forecasts by Process (Upstream Process, Downstream Process), by Downstream (Fill & Finish Operations, Analytical & QC Studies, Vaccine Packaging), by Upstream (Mammalian Expression Vaccine, Bacterial Expression Vaccine, Yeast Expression Vaccine, Baculovirus/Insect Expression Vaccine, Other), by Type (Subunit Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Inactivated Vaccines, Recombinant Vector Vaccines, Other), by Company Size (Small Manufacturers, Mid-sized Manufacturers, Large Manufacturers, Very Large Manufacturers), by Operation (Preclinical, Clinical, Commercial, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
The Vaccine Contract Manufacturing Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Factors Such As Reduced Market Time, Infrastructure Cost Benefits, And Operational Benefits Are Driving The Market Growth
Some of the major forces propelling the global vaccine contract manufacturing market include reduced market time, infrastructure cost, and operational benefits. Furthermore, technical advancements such as the development of new expression systems like GPEx and EB66 cell lines and cell culture medium platforms are expected to propel market growth. On the other hand, few large organizations consider outsourcing to be harmful due to the loss of strategic and management control. Considerable investments in facilities, equipment, and skilled labour in countries looking to grow or localise their supply are expected to impact contract services adoption positively. In addition, several low-resource countries lack the requisite equipment and experienced personnel to manufacture vaccines, leading them to create contracts with contract producers to meet market demand.
On the other hand, few large organizations see outsourcing as a concern since it results in a loss of strategic and management control. As a result, big pharmaceutical companies prefer to maintain their manufacturing in-house. This aspect is predicted to hinder global acceptance of contract services over the forecast period.
Logistical And Administrative Challenges
Local governments will need a robust data infrastructure to identify eligible persons by priority group, make invites, organise transportation for elderly and disabled patients, and recall individuals to obtain second doses of particular vaccines. Several of the most promising vaccine ideas necessitate ultra-cold chains and have a short shelf life once extracted from storage. BioNTech and Pfizer’s mRNA vaccines, for example, must be administered within five days of leaving ultra-low temperature settings (–70°C); Moderna’s mRNA vaccine has similar, if less stringent, restrictions. Strong coordination between central depots & local vaccinators would be necessary to ensure the timely & effective delivery of mRNA vaccine batches to regions without freezers.
What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the vaccine contract manufacturing market evolving?
• What is driving and restraining the vaccine contract manufacturing market?
• How will each vaccine contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each vaccine contract manufacturing submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the vaccine contract manufacturing projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implication of vaccine contract manufacturing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the vaccine contract manufacturing market?
• Where is the vaccine contract manufacturing market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the vaccine contract manufacturing market today, and over the next 10 years:
• Our 565-page report provides 377 tables and 379 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the vaccine contract manufacturing market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising vaccine contract manufacturing prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Segments Covered in the Report
Process Outlook
• Upstream Process
– Mammalian Expression Vaccine
– Bacterial Expression Vaccine
– Yeast Expression Vaccine
– Baculovirus/Insect Expression Vaccine
– Other Upstream
• Downstream Process
– Fill & Finish Operations
– Analytical & QC Studies
– Vaccine Packaging
Type
• Subunit Vaccines
• Live Attenuated Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Recombinant Vector Vaccines
• Other Vaccine Type
Company Size
• Small Manufacturers
• Mid-sized Manufacturers
• Large Manufacturers
• Very Large Manufacturers
Operation
• Preclinical
• Clinical
• Commercial
• Other Operations
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Rest of Latin America
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Vaccine Contract Manufacturing Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• AbbVie Inc. (AbbVie)
• Bavarian Nordic A/S
• Catalent, Inc.
• Charles River Laboratories International, Inc.
• Emergent BioSolutions Inc.
• Eurofins Scientific SE
• FUJIFILM Holdings Corporation
• GlaxoSmithKline PLC
• Kemwell Biopharma
• Lonza Group AG (Lonza)
• Merck KGaA
• Pfizer Inc. (Pfizer)
• Richter-Helm BioLogics
• Samsung Biologics Co Ltd
• Sanofi SA
• Serum Institute of India
• Siegfried Holding AG
• Thermo Fisher Scientific Inc.
• Wacker Biotech B.V
• WuXi Biologics Cayman Inc
Overall world revenue for Vaccine Contract Manufacturing Market, 2022 to 2032 in terms of value the market will surpass US$2,676 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Vaccine Contract Manufacturing Market, 2022 to 2032 Market report helps you?
In summary, our 560+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Vaccine Contract Manufacturing Market, 2022 to 2032 Market, with forecasts for Process, upstream, downstream, type company size each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2032 for 4 regional and 20 key national markets – See forecasts for the Vaccine Contract Manufacturing Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 20 of the major companies involved in the Vaccine Contract Manufacturing Market, 2022 to 2032 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Vaccine Contract Manufacturing Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Vaccine Contract Manufacturing Market Report 2022-2032: Forecasts by Process (Upstream Process, Downstream Process), by Downstream (Fill & Finish Operations, Analytical & QC Studies, Vaccine Packaging), by Upstream (Mammalian Expression Vaccine, Bacterial Expression Vaccine, Yeast Expression Vaccine, Baculovirus/Insect Expression Vaccine, Other), by Type (Subunit Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Inactivated Vaccines, Recombinant Vector Vaccines, Other), by Company Size (Small Manufacturers, Mid-sized Manufacturers, Large Manufacturers, Very Large Manufacturers), by Operation (Preclinical, Clinical, Commercial, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Introduction to Vaccine Contract Manufacturing Market
1.2 Global Vaccine Contract Manufacturing Market Overview
1.3 What are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Why You Should Read This Report
1.6 What This Report Delivers
1.7 Key Questions Answered By This Analytical Report Include:
1.8 Who is This Report for?
1.9 Research Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions (FAQs)
1.11 Associated Visiongain Reports
1.12 About Visiongain
2 Executive Summary
3 Global Market Dynamics
3.1 COVID-19 Impact on Global Market:
3.2 Current Trends in the Global Market
3.3 Market Driving Factors
3.3.1 Growth In Infectious Diseases
3.3.2 Stakeholder Cooperation Maximises Manufacturing Capacity
3.3.3 Implications Beyond COVID-19
3.4 Market Restraining Factors
3.4.1 Material And Equipment Shortages
3.4.2 Manufacturing Process Complexity
3.4.3 Capacity Constraints
3.5 Opportunities in the Global Market
3.5.1 New Vaccine Technologies
3.5.1.1 Gene-based vaccines
3.5.1.2 VLPs
3.5.1.3 Plant-derived vaccines
3.5.1.4 Novel adjuvants and delivery systems.
3.6 Challenges in the Global Market
3.6.1 Unprecedented Vaccine Production Demand
3.6.2 Logistical And Administrative Challenges
3.6.3 Vaccine Hesitancy
3.7 SWOT Analysis
3.7.1 Strength
3.7.1.1 Growth In Infectious Diseases
3.7.1.2 Stakeholder Cooperation Maximises Manufacturing Capacity
3.7.1.3 Implications Beyond COVID-19
3.7.2 Weakness
3.7.2.1 Material And Equipment Shortages
3.7.2.2 Manufacturing Process Complexity
3.7.2.3 Capacity Constraints
3.7.3 Opportunities
3.7.3.1 New Vaccine Technologies
3.7.4 Threats
3.7.4.1 Unprecedented Vaccine Production Demand
3.7.4.2 Logistical And Administrative Challenges
3.7.4.3 Vaccine Hesitancy
3.8 PEST Analysis:
3.8.1 Political Factors
3.8.2 Economic Factors
3.8.3 Sociocultural Factors
3.8.4 Technological Factors
3.9 Porter’s Five Forces Analysis
3.9.1 What are Porter Five (5) Forces
3.9.2 Threat of New Entrants (Low to Moderate)
3.9.3 Rivalry Among the Existing Players (High)
3.9.4 Bargaining Power of Suppliers (Low)
3.9.5 Threats from Substitute Products (Low to Moderate)
3.9.6 Bargaining Power of Buyers (High)
4 Global Vaccine Contract Manufacturing Market Analysis
4.1 Global Market Outlook
4.2 Global Market Size Estimation and Forecast
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5 Global Vaccine Contract Manufacturing Market Analysis By Region
5.1 North America
5.2 Europe
5.3 Asia Pacific
5.4 LAMEA
5.5 Regional Market Size Estimation and Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Vaccine Contract Manufacturing Market Analysis By Process
6.1 Upstream Process
6.2 Downstream Process
6.3 Global Market Size Estimation and Forecast By Process
6.3.1 Pre-COVID-19 Market Scenario
6.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Vaccine Contract Manufacturing Market Analysis By Downstream
7.1 Fill & Finish Operations
7.2 Analytical & QC Studies
7.3 Vaccine Packaging
7.4 Global Market Size Estimation and Forecast By Downstream
7.4.1 Pre-COVID-19 Market Scenario
7.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Vaccine Contract Manufacturing Market Analysis By Upstream
8.1 Mammalian Expression Vaccine Type
8.2 Bacterial Expression Vaccine Type
8.3 Yeast Expression Vaccine Type
8.4 Baculovirus/Insect Expression Vaccine Type
8.5 Other Upstream Process
8.6 Global Market Size Estimation and Forecast By Upstream
8.6.1 Pre-COVID-19 Market Scenario
8.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Vaccine Contract Manufacturing Market Analysis By Vaccine Type
9.1 Subunit Vaccines
9.2 Live Attenuated Vaccines
9.3 Conjugate Vaccines
9.4 Inactivated Vaccines
9.5 Recombinant Vector Vaccines
9.6 Other Vaccine Type
9.7 Global Market Size Estimation and Forecast By Vaccine Type
9.7.1 Pre-COVID-19 Market Scenario
9.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Vaccine Contract Manufacturing Market Analysis By Company Size
10.1 Global Market Size Estimation and Forecast By Company Size
10.1.1 Pre-COVID-19 Market Scenario
10.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Global Vaccine Contract Manufacturing Market Analysis By Operation
11.1 Preclinical
11.2 Clinical
11.3 Commercial
11.4 Global Market Size Estimation and Forecast By Operation
11.4.1 Pre-COVID-19 Market Scenario
11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 North America Vaccine Contract Manufacturing Market Analysis
12.1 North American Countries Have The Most Demanding Legislation Regulating And Controlling Pharmaceuticals’ Distribution And Production
12.2 North America Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Country Market Size Estimation and Forecast
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and Forecast By Process
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast By Downstream
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast By Upstream
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast By Vaccine Type
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 North America Market Size Estimation and Forecast By Company Size
12.8.1 Pre-COVID-19 Market Scenario
12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 North America Market Size Estimation and Forecast By Operation
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 US Vaccine Contract Manufacturing Market Analysis
12.10.1 Collaboration Between GSK and Vir Biotechnology to Purchase Additional Supply of Sotrovimab
12.10.2 Pre-COVID-19 Market Scenario
12.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Canada Vaccine Contract Manufacturing Market Analysis
12.11.1 Emergent Biosolutions Secures Multi-Year Development And Manufacturing Agreement With Providence Therapeutics For Its Mrna COVID-19 Vaccine Candidate, PTX-COVID19-B
12.11.2 Pre-COVID-19 Market Scenario
12.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Mexico Vaccine Contract Manufacturing Market Analysis
12.12.1 First COVID-19 Vaccine Fill-Finish Manufacturing In Mexico Completed
12.12.2 Pre-COVID-19 Market Scenario
12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Europe Vaccine Contract Manufacturing Market Analysis
13.1 EU Watchdog Okays Production Capacity Hikes For J&J, Moderna, Pfizer Vaccines
13.2 European Commission Approves Contract With Valneva To Secure A New Potential Vaccine
13.3 Europe Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Country Market Size Estimation and Forecast
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and Forecast By Process
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast By Downstream
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast By Upstream
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast By Vaccine Type
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Europe Market Size Estimation and Forecast By Company Size
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 Europe Market Size Estimation and Forecast By Operation
13.10.1 Pre-COVID-19 Market Scenario
13.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 Germany Vaccine Contract Manufacturing Market Analysis
13.11.1 Curevac Slashes COVID-19 Vaccine Production Plans
13.11.2 Pre-COVID-19 Market Scenario
13.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 UK Vaccine Contract Manufacturing Market Analysis
13.12.1 UK Reportedly Selling £200m Vaccine Plant That Never Produced A Single Dose
13.12.2 Pre-COVID-19 Market Scenario
13.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 France Vaccine Contract Manufacturing Market Analysis
13.13.1 Recipharm Secures Vaccine Manufacturing Deal With Top 10 Big Pharma And Will Provide Manufacturing Support From Facility In Kaysersberg, France
13.13.2 Pre-COVID-19 Market Scenario
13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Italy Vaccine Contract Manufacturing Market Analysis
13.14.1 Aenova’s Biologics And Vaccines Manufacturing Facility Expansion, Latina, Italy
13.14.2 Pre-COVID-19 Market Scenario
13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Spain Vaccine Contract Manufacturing Market Analysis
13.15.1 Moderna And ROVI Expand Long-Term Collaboration For The Manufacture Of MRNA Medicines Over The Next Ten Years
13.15.2 Pre-COVID-19 Market Scenario
13.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.16 Rest of Europe Vaccine Contract Manufacturing Market Analysis
13.16.1 Pre-COVID-19 Market Scenario
13.16.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 Asia-Pacific Vaccine Contract Manufacturing Market Analysis
14.1 Asia Pacific Must Fix Its Broken Vaccine System
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast By Process
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and Forecast By Downstream
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast By Upstream
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast By Vaccine Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast By Company Size
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Asia-Pacific Market Size Estimation and Forecast By Operation
14.9.1 Pre-COVID-19 Market Scenario
14.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 China Vaccine Contract Manufacturing Market Analysis
14.10.1 China Is Manufacturing Vaccines In Africa.
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 India Vaccine Contract Manufacturing Market Analysis
14.11.1 Serum Institute Invests $68m In Oxford Biomedica To Expand Vector Capacity
14.11.2 Pre-COVID-19 Market Scenario
14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Japan Vaccine Contract Manufacturing Market Analysis
14.12.1 Japan's Takara Bio To Launch Contract Production Of Mrna Vaccines
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 South Korea Vaccine Contract Manufacturing Market Analysis
14.13.1 Moderna, Novavax To Produce More COVID-19 Vaccines In South Korea
14.13.2 South Korea’s SK Bioscience Expands Manufacturing Agreement For Novavax’s COVID-19 Vaccine
14.13.3 Pre-COVID-19 Market Scenario
14.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Australia Vaccine Contract Manufacturing Market Analysis
14.14.1 Novavax Hunts For Australian Manufacturer As CSL Homes In On AstraZeneca Vaccine Production
14.14.2 Australia Plans To Stop AstraZeneca Vaccine Production
14.14.3 Pre-COVID-19 Market Scenario
14.14.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.15 Rest of Asia-Pacific Vaccine Contract Manufacturing Market Analysis
14.15.1 Pre-COVID-19 Market Scenario
14.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 LAMEA Vaccine Contract Manufacturing Market Analysis
15.1 PAHO Welcomes First WHO Emergency Use Listing Of COVID-19 Vaccine Produced In Latin America
15.2 Brazil And Argentina Tapped To Make mRNA Vaccines In Latin America
15.3 LAMEA Market Size Estimation and Forecast
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 Country Market Size Estimation and Forecast
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and Forecast By Process
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast By Downstream
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast By Upstream
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast By Vaccine Type
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 LAMEA Market Size Estimation and Forecast By Company Size
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 LAMEA Market Size Estimation and Forecast By Operation
15.10.1 Pre-COVID-19 Market Scenario
15.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 Brazil Vaccine Contract Manufacturing Market Analysis
15.11.1 Pfizer, Biontech Sign On With Eurofarma Of Brazil For COVID-19 Vaccine Production
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.12 South Africa Vaccine Contract Manufacturing Market Analysis
15.12.1 Janssen And Aspen Enter Deal To Manufacture Covid-19 Vaccine In Africa
15.12.2 Pre-COVID-19 Market Scenario
15.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.13 Saudi Arabia Vaccine Contract Manufacturing Market Analysis
15.13.1 Saudi Arabia Agrees Deal With GSK To Develop Healthcare Sector
15.13.2 Pre-COVID-19 Market Scenario
15.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.14 Turkey Vaccine Contract Manufacturing Market Analysis
15.14.1 Turkey Renews SK Bioscience’s Vaccine Manufacturing Certification
15.14.2 Pre-COVID-19 Market Scenario
15.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.15 UAE Vaccine Contract Manufacturing Market Analysis
15.15.1 Mubadala, G42 To Set Up Biopharma Manufacturing Campus In Abu Dhabi
15.15.2 Pre-COVID-19 Market Scenario
15.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.16 Rest of LAMEA Vaccine Contract Manufacturing Market Analysis
15.16.1 Pre-COVID-19 Market Scenario
15.16.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16 Company Profiles
16.1 Catalent
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product/Service Benchmarking
16.1.5 Company Recent Developments
16.2 Emergent BioSolutions
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product/Service Benchmarking
16.2.5 Company Recent Developments
16.3 GlaxoSmithKline
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product/Service Benchmarking
16.3.5 Company Recent Developments
16.4 Lonza Group AG
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financial Profile
16.4.4 Company Product/Service Benchmarking
16.4.5 Company Recent Developments
16.5 Merck KGaA
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Financial Profile
16.5.4 Company Product/Service Benchmarking
16.5.5 Company Recent Developments
16.6 Pfizer
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Financial Profile
16.6.4 Company Product/Service Benchmarking
16.6.5 Company Recent Developments
16.7 Siegfried Holding
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financial Profile
16.7.4 Company Product/Service Benchmarking
16.7.5 Company Recent Developments
16.8 Sanofi
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Financial Profile
16.8.4 Company Product/Service Benchmarking
16.9 Bavarian Nordic
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financial Profile
16.9.4 Company Product/Service Benchmarking
16.10 FUJIFILM Holdings Corp
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Financial Profile
16.10.1 Company Product/Service Benchmarking
16.11 Charles River Laboratories
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Company Financial Profile
16.11.4 Company Product/Service Benchmarking
16.11.5 Company Recent Developments
16.12 Samsung Biologics
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Company Financial Profile
16.12.4 Company Product/Service Benchmarking
16.12.5 Company Recent Developments
16.13 AbbVie
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Company Financial Profile
16.13.4 Company Product/Service Benchmarking
16.14 Thermo Fisher Scientific Inc
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Company Financial Profile
16.14.4 Company Product/Service Benchmarking
16.14.5 Company Recent Developments
16.15 Eurofins Scientific
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Company Financial Profile
16.15.4 Company Product/Service Benchmarking
16.15.5 Company Recent Developments
16.16 WuXi Biologics
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Company Financial Profile
16.16.4 Company Product/Service Benchmarking
16.16.5 Company Recent Developments
16.17 Serum Institute of India
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Company Product/Service Benchmarking
16.17.4 Company Recent Developments
16.18 Richter-Helm BioLogics
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Company Product/Service Benchmarking
16.18.4 Company Recent Developments
16.19 Wacker Biotech B.V
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Company Product/Service Benchmarking
16.20 Kemwell Biopharma
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Company Product/Service Benchmarking
17 Conclusion
17.1 Concluding Remarks
17.2 Recommendations
List of Tables
Table 1. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 2. Global Vaccine Contract Manufacturing Market Snapshot, 2022 & 2032 (US$million, CAGR %)
Table 3. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 4. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 5. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 6. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 7. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 8. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 9. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 10. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 11. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 12. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 13. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 14. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 15. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 16. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 17. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 18. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 19. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 20. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 21. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 22. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 23. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 24. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 25. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 26. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 27. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 28. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 29. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 30. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 31. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 32. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 33. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 34. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 35. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 36. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 37. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 38. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 39. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 40. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 41. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 42. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 43. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 44. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 45. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 46. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 47. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 48. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 49. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 50. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 51. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 52. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 53. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 54. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 55. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 56. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 57. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 58. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 59. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 60. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 61. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 62. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 63. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 64. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 65. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 66. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 67. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 68. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 69. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 70. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 71. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 72. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 73. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 74. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 75. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 76. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 77. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 78. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 79. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 80. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 81. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 82. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 83. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 84. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 85. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 86. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 87. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 88. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 89. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 90. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 91. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 92. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 93. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 94. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 95. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 96. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 97. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 98. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 99. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 100. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 101. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 102. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 103. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 104. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 105. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 106. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 107. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 108. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 109. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 110. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 111. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 112. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 113. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 114. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 115. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 116. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 117. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 118. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 119. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 120. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 121. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 122. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 123. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 124. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 125. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 126. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 127. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 128. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 129. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 130. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 131. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 132. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 133. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 134. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 135. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 136. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 137. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 138. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 139. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 140. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 141. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 142. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 143. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 144. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 145. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 146. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 147. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 148. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 149. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 150. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 151. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 152. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 153. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 154. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 155. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 156. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 157. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 158. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 159. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 160. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 161. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 162. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 163. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 164. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 165. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 166. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 167. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 168. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 169. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 170. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 171. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 172. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 173. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 174. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 175. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 176. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 177. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 178. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 179. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 180. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 181. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 182. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 183. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 184. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 185. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 186. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 187. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 188. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 189. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 190. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 191. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 192. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 193. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 194. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 195. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 196. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 197. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 198. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 199. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 200. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 201. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 202. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 203. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 204. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 205. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 206. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 207. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 208. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 209. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 210. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 211. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 212. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 213. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 214. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 215. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 216. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 217. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 218. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 219. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 220. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 221. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 222. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 223. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 224. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 225. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 226. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 227. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 228. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 229. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 230. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 231. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 232. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 233. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 234. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 235. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 236. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 237. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 238. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 239. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 240. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 241. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 242. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 243. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 244. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 245. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 246. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 247. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 248. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 249. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 250. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 251. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 252. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 253. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 254. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 255. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 256. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 257. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 258. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 259. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 260. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 261. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 262. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 263. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 264. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 265. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 266. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 267. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 268. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 269. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 270. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 271. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 272. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 273. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 274. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 275. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 276. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 277. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 278. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 279. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 280. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 281. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 282. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 283. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 284. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 285. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 286. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 287. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 288. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 289. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 290. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 291. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 292. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 293. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 294. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 295. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 296. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 297. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 298. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 299. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 300. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 301. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 302. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 303. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 304. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 305. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 306. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 307. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 308. Catalent: Company Information
Table 309. Catalent: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 310. Catalent: Company Product and Service Benchmarking
Table 311. Catalent: Company Recent Developments till Feb,2021
Table 312. Emergent BioSolutions: Company Information
Table 313. Emergent BioSolutions: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 314. Emergent BioSolutions: Company Product and Service Benchmarking
Table 315. Emergent BioSolutions: Company Recent Developments
Table 316. GlaxoSmithKline: Company Information
Table 317. GlaxoSmithKline: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 318. GlaxoSmithKline: Company Product and Service Benchmarking
Table 319. GlaxoSmithKline: Company Recent Developments
Table 320. Lonza Group AG: Company Information
Table 321. Lonza Group AG: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 322. Lonza Group AG : Company Product and Service Benchmarking
Table 323. Lonza Group AG: Company Recent Developments till Feb,2021
Table 324. Merck KGaA: Company Information
Table 325. Merck KGaA: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 326. Merck KGaA: Company Product and Service Benchmarking
Table 327. Merck KGaA: Company Recent Developments
Table 328. Pfizer: Company Information
Table 329. Pfizer: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 330. Pfizer: Company Product and Service Benchmarking
Table 331. Pfizer: Company Recent Developments
Table 332. Siegfried Holding: Company Information
Table 333. Siegfried Holding: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 334. Siegfried Holding: Company Product and Service Benchmarking
Table 335. Siegfried Holding: Company Recent Developments till Feb,2021
Table 336. Sanofi: Company Information
Table 337. Sanofi: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 338. Sanofi: Company Product and Service Benchmarking
Table 339. Bavarian Nordic: Company Information
Table 340. Bavarian Nordic: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 341. Bavarian Nordic: Company Product and Service Benchmarking
Table 342. FUJIFILM Holdings Corp: Company Information
Table 343. FUJIFILM Holdings Corp: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 344. FUJIFILM Holdings Corporation : Company Product and Service Benchmarking
Table 345. Charles River Laboratories: Company Information
Table 346. Charles River Laboratories: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 347. Charles River Laboratories: Company Product and Service Benchmarking
Table 348. Charles River Laboratories: Company Recent Developments till Feb,2021
Table 349. Samsung Biologics: Company Information
Table 350. Samsung Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 351. Samsung Biologics: Company Product and Service Benchmarking
Table 352. Samsung Biologics: Company Recent Developments
Table 353. AbbVie: Company Information
Table 354. AbbVie: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 355. AbbVie: Company Product and Service Benchmarking
Table 356. Thermo Fisher Scientific Inc: Company Information
Table 357. Thermo Fisher Scientific Inc: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 358. Thermo Fisher Scientific Inc: Company Product and Service Benchmarking
Table 359. Thermo Fisher Scientific Inc: Company Recent Developments till Feb,2021
Table 360. Eurofins Scientific: Company Information
Table 361. Eurofins Scientific: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 362. Eurofins Scientific: Company Product and Service Benchmarking
Table 363. Eurofins Scientific: Company Recent Developments
Table 364. WuXi Biologics: Company Information
Table 365. WuXi Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 366. WuXi Biologics: Company Product and Service Benchmarking
Table 367. WuXi Biologics: Company Recent Developments till Feb,2021
Table 368. Serum Institute of India: Company Information
Table 369. Serum Institute of India: Company Product and Service Benchmarking
Table 370. Serum Institute of India: Company Recent Developments
Table 371. Richter-Helm BioLogics: Company Information
Table 372. Richter-Helm BioLogics: Company Product and Service Benchmarking
Table 373. Richter-Helm BioLogics: Company Recent Developments
Table 374. Wacker Biotech B.V: Company Information
Table 375. Wacker Biotech B.V: Company Product and Service Benchmarking
Table 376. Kemwell Biopharma: Company Information
Table 377. Kemwell Biopharma: Company Product and Service Benchmarking
List of Figures
Figure 1. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 2. Global Vaccine Contract Manufacturing Market Segmentation
Figure 3. Global Vaccine Contract Manufacturing Market Trends :
Figure 4. Porter’s Five Forces Analysis of Vaccine Contract Manufacturing Market
Figure 5. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 6. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 7. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 8. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 9. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 10. Global Vaccine Contract Manufacturing Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 11. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 12. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Figure 13. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Figure 14. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Figure 15. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Figure 16. Global Vaccine Contract Manufacturing Market Share Forecast by Process 2022, 2027, 2032(%)
Figure 17. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 18. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 19. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 20. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 21. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 22. Global Vaccine Contract Manufacturing Market Share Forecast by Downstream 2022, 2027, 2032(%)
Figure 23. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 24. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 25. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 26. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 27. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 28. Global Vaccine Contract Manufacturing Market Share Forecast by Upstream 2022, 2027, 2032(%)
Figure 29. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 30. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 31. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 32. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 33. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 34. Global Vaccine Contract Manufacturing Market Share Forecast by Vaccine Type 2022, 2027, 2032(%)
Figure 35. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 36. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 37. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 38. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 39. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 40. Global Vaccine Contract Manufacturing Market Share Forecast by Company Size 2022, 2027, 2032(%)
Figure 41. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 42. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 43. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 44. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 45. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 46. Global Vaccine Contract Manufacturing Market Share Forecast by Operation 2022, 2027, 2032(%)
Figure 47. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 48. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 49. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 50. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 51. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 52. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 53. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 54. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 55. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 56. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 57. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 58. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 59. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 60. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 61. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 62. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 63. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 64. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 65. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 66. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 67. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 68. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 69. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 70. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 71. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 72. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 73. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 74. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 75. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 76. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 77. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 78. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 79. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 80. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 81. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 82. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 83. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 84. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 85. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 86. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 87. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 88. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 89. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 90. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 91. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 92. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 93. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 94. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 95. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 96. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 97. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 98. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 99. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 100. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 101. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 102. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 103. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 104. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 105. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 106. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 107. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 108. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 109. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 110. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 111. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 112. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 113. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 114. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 115. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 116. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 117. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 118. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 119. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 120. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 121. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 122. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 123. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 124. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 125. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 126. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 127. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 128. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 129. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 130. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 131. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 132. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 133. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 134. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 135. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 136. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 137. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 138. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 139. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 140. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 141. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 142. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 143. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 144. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 145. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 146. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 147. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 148. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 149. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 150. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 151. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 152. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 153. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 154. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 155. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 156. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 157. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 158. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 159. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 160. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 161. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 162. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 163. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 164. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 165. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 166. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 167. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 168. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 169. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 170. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 171. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 172. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 173. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 174. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 175. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 176. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 177. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 178. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 179. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 180. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 181. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 182. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 183. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 184. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 185. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 186. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 187. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 188. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 189. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 190. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 191. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 192. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 193. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 194. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 195. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 196. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 197. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 198. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 199. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 200. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 201. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 202. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 203. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 204. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 205. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 206. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 207. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 208. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 209. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 210. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 211. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 212. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 213. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 214. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 215. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 216. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 217. China Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 218. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 219. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 220. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 221. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 222. India Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 223. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 224. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 225. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 226. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 227. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 228. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 229. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 230. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 231. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 232. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 233. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 234. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 235. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 236. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 237. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 238. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 239. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 240. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 241. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 242. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 243. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 244. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 245. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 246. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 247. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 248. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 249. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 250. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 251. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 252. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 253. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 254. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 255. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 256. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 257. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 258. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 259. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 260. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 261. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 262. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 263. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 264. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 265. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 266. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 267. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 268. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 269. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 270. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 271. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 272. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 273. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 274. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 275. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 276. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 277. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 278. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 279. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 280. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 281. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 282. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 283. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 284. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 285. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 286. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 287. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 288. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 289. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 290. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 291. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 292. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 293. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 294. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 295. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 296. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 297. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 298. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 299. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 300. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 301. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 302. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 303. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 304. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 305. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 306. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 307. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 308. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 309. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 310. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 311. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 312. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 313. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 314. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 315. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 316. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 317. Catalent: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 318. Catalent: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 319. Catalent: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 320. Catalent: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 321. Emergent BioSolutions: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 322. Emergent BioSolutions: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 323. Emergent BioSolutions: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 324. Emergent BioSolutions: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 325. GlaxoSmithKline: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 326. GlaxoSmithKline: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 327. GlaxoSmithKline: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 328. GlaxoSmithKline: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 329. Lonza Group AG: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 330. Lonza Group AG: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 331. Lonza Group AG: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 332. Lonza Group AG: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 333. Merck KGaA: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 334. Merck KGaA: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 335. Merck KGaA: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 336. Merck KGaA: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 337. Pfizer: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 338. Pfizer: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 339. Pfizer: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 340. Pfizer: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 341. Siegfried Holding: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 342. Siegfried Holding: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 343. Siegfried Holding: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 344. Siegfried Holding: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 345. Sanofi: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 346. Sanofi: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 347. Sanofi: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 348. Sanofi: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 349. Bavarian Nordic: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 350. Bavarian Nordic: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 351. Bavarian Nordic: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 352. Bavarian Nordic: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 353. FUJIFILM Holdings Corp: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 354. FUJIFILM Holdings Corp: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 355. FUJIFILM Holdings Corp: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 356. FUJIFILM Holdings Corp: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 357. Charles River Laboratories: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 358. Charles River Laboratories: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 359. Charles River Laboratories: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 360. Charles River Laboratories: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 361. Samsung Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 362. Samsung Biologics: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 363. Samsung Biologics: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 364. Samsung Biologics: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 365. AbbVie: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 366. AbbVie: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 367. AbbVie: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 368. AbbVie: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 369. Thermo Fisher Scientific Inc: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 370. Thermo Fisher Scientific Inc: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 371. Thermo Fisher Scientific Inc: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 372. Thermo Fisher Scientific Inc: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 373. Eurofins Scientific: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 374. Eurofins Scientific: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 375. Eurofins Scientific: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 376. Eurofins Scientific: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 377. WuXi Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 378. WuXi Biologics: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 379. WuXi Biologics: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 380. WuXi Biologics: Company EBITDA 2016-2020 (US$Mn, AGR %)
1.1 Introduction to Vaccine Contract Manufacturing Market
1.2 Global Vaccine Contract Manufacturing Market Overview
1.3 What are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Why You Should Read This Report
1.6 What This Report Delivers
1.7 Key Questions Answered By This Analytical Report Include:
1.8 Who is This Report for?
1.9 Research Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions (FAQs)
1.11 Associated Visiongain Reports
1.12 About Visiongain
2 Executive Summary
3 Global Market Dynamics
3.1 COVID-19 Impact on Global Market:
3.2 Current Trends in the Global Market
3.3 Market Driving Factors
3.3.1 Growth In Infectious Diseases
3.3.2 Stakeholder Cooperation Maximises Manufacturing Capacity
3.3.3 Implications Beyond COVID-19
3.4 Market Restraining Factors
3.4.1 Material And Equipment Shortages
3.4.2 Manufacturing Process Complexity
3.4.3 Capacity Constraints
3.5 Opportunities in the Global Market
3.5.1 New Vaccine Technologies
3.5.1.1 Gene-based vaccines
3.5.1.2 VLPs
3.5.1.3 Plant-derived vaccines
3.5.1.4 Novel adjuvants and delivery systems.
3.6 Challenges in the Global Market
3.6.1 Unprecedented Vaccine Production Demand
3.6.2 Logistical And Administrative Challenges
3.6.3 Vaccine Hesitancy
3.7 SWOT Analysis
3.7.1 Strength
3.7.1.1 Growth In Infectious Diseases
3.7.1.2 Stakeholder Cooperation Maximises Manufacturing Capacity
3.7.1.3 Implications Beyond COVID-19
3.7.2 Weakness
3.7.2.1 Material And Equipment Shortages
3.7.2.2 Manufacturing Process Complexity
3.7.2.3 Capacity Constraints
3.7.3 Opportunities
3.7.3.1 New Vaccine Technologies
3.7.4 Threats
3.7.4.1 Unprecedented Vaccine Production Demand
3.7.4.2 Logistical And Administrative Challenges
3.7.4.3 Vaccine Hesitancy
3.8 PEST Analysis:
3.8.1 Political Factors
3.8.2 Economic Factors
3.8.3 Sociocultural Factors
3.8.4 Technological Factors
3.9 Porter’s Five Forces Analysis
3.9.1 What are Porter Five (5) Forces
3.9.2 Threat of New Entrants (Low to Moderate)
3.9.3 Rivalry Among the Existing Players (High)
3.9.4 Bargaining Power of Suppliers (Low)
3.9.5 Threats from Substitute Products (Low to Moderate)
3.9.6 Bargaining Power of Buyers (High)
4 Global Vaccine Contract Manufacturing Market Analysis
4.1 Global Market Outlook
4.2 Global Market Size Estimation and Forecast
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5 Global Vaccine Contract Manufacturing Market Analysis By Region
5.1 North America
5.2 Europe
5.3 Asia Pacific
5.4 LAMEA
5.5 Regional Market Size Estimation and Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Vaccine Contract Manufacturing Market Analysis By Process
6.1 Upstream Process
6.2 Downstream Process
6.3 Global Market Size Estimation and Forecast By Process
6.3.1 Pre-COVID-19 Market Scenario
6.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Vaccine Contract Manufacturing Market Analysis By Downstream
7.1 Fill & Finish Operations
7.2 Analytical & QC Studies
7.3 Vaccine Packaging
7.4 Global Market Size Estimation and Forecast By Downstream
7.4.1 Pre-COVID-19 Market Scenario
7.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Vaccine Contract Manufacturing Market Analysis By Upstream
8.1 Mammalian Expression Vaccine Type
8.2 Bacterial Expression Vaccine Type
8.3 Yeast Expression Vaccine Type
8.4 Baculovirus/Insect Expression Vaccine Type
8.5 Other Upstream Process
8.6 Global Market Size Estimation and Forecast By Upstream
8.6.1 Pre-COVID-19 Market Scenario
8.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Vaccine Contract Manufacturing Market Analysis By Vaccine Type
9.1 Subunit Vaccines
9.2 Live Attenuated Vaccines
9.3 Conjugate Vaccines
9.4 Inactivated Vaccines
9.5 Recombinant Vector Vaccines
9.6 Other Vaccine Type
9.7 Global Market Size Estimation and Forecast By Vaccine Type
9.7.1 Pre-COVID-19 Market Scenario
9.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Vaccine Contract Manufacturing Market Analysis By Company Size
10.1 Global Market Size Estimation and Forecast By Company Size
10.1.1 Pre-COVID-19 Market Scenario
10.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Global Vaccine Contract Manufacturing Market Analysis By Operation
11.1 Preclinical
11.2 Clinical
11.3 Commercial
11.4 Global Market Size Estimation and Forecast By Operation
11.4.1 Pre-COVID-19 Market Scenario
11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 North America Vaccine Contract Manufacturing Market Analysis
12.1 North American Countries Have The Most Demanding Legislation Regulating And Controlling Pharmaceuticals’ Distribution And Production
12.2 North America Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Country Market Size Estimation and Forecast
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and Forecast By Process
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast By Downstream
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast By Upstream
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast By Vaccine Type
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 North America Market Size Estimation and Forecast By Company Size
12.8.1 Pre-COVID-19 Market Scenario
12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 North America Market Size Estimation and Forecast By Operation
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 US Vaccine Contract Manufacturing Market Analysis
12.10.1 Collaboration Between GSK and Vir Biotechnology to Purchase Additional Supply of Sotrovimab
12.10.2 Pre-COVID-19 Market Scenario
12.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Canada Vaccine Contract Manufacturing Market Analysis
12.11.1 Emergent Biosolutions Secures Multi-Year Development And Manufacturing Agreement With Providence Therapeutics For Its Mrna COVID-19 Vaccine Candidate, PTX-COVID19-B
12.11.2 Pre-COVID-19 Market Scenario
12.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Mexico Vaccine Contract Manufacturing Market Analysis
12.12.1 First COVID-19 Vaccine Fill-Finish Manufacturing In Mexico Completed
12.12.2 Pre-COVID-19 Market Scenario
12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Europe Vaccine Contract Manufacturing Market Analysis
13.1 EU Watchdog Okays Production Capacity Hikes For J&J, Moderna, Pfizer Vaccines
13.2 European Commission Approves Contract With Valneva To Secure A New Potential Vaccine
13.3 Europe Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Country Market Size Estimation and Forecast
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and Forecast By Process
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast By Downstream
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast By Upstream
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast By Vaccine Type
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Europe Market Size Estimation and Forecast By Company Size
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 Europe Market Size Estimation and Forecast By Operation
13.10.1 Pre-COVID-19 Market Scenario
13.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 Germany Vaccine Contract Manufacturing Market Analysis
13.11.1 Curevac Slashes COVID-19 Vaccine Production Plans
13.11.2 Pre-COVID-19 Market Scenario
13.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 UK Vaccine Contract Manufacturing Market Analysis
13.12.1 UK Reportedly Selling £200m Vaccine Plant That Never Produced A Single Dose
13.12.2 Pre-COVID-19 Market Scenario
13.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 France Vaccine Contract Manufacturing Market Analysis
13.13.1 Recipharm Secures Vaccine Manufacturing Deal With Top 10 Big Pharma And Will Provide Manufacturing Support From Facility In Kaysersberg, France
13.13.2 Pre-COVID-19 Market Scenario
13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Italy Vaccine Contract Manufacturing Market Analysis
13.14.1 Aenova’s Biologics And Vaccines Manufacturing Facility Expansion, Latina, Italy
13.14.2 Pre-COVID-19 Market Scenario
13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Spain Vaccine Contract Manufacturing Market Analysis
13.15.1 Moderna And ROVI Expand Long-Term Collaboration For The Manufacture Of MRNA Medicines Over The Next Ten Years
13.15.2 Pre-COVID-19 Market Scenario
13.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.16 Rest of Europe Vaccine Contract Manufacturing Market Analysis
13.16.1 Pre-COVID-19 Market Scenario
13.16.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 Asia-Pacific Vaccine Contract Manufacturing Market Analysis
14.1 Asia Pacific Must Fix Its Broken Vaccine System
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast By Process
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and Forecast By Downstream
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast By Upstream
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast By Vaccine Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast By Company Size
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Asia-Pacific Market Size Estimation and Forecast By Operation
14.9.1 Pre-COVID-19 Market Scenario
14.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 China Vaccine Contract Manufacturing Market Analysis
14.10.1 China Is Manufacturing Vaccines In Africa.
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 India Vaccine Contract Manufacturing Market Analysis
14.11.1 Serum Institute Invests $68m In Oxford Biomedica To Expand Vector Capacity
14.11.2 Pre-COVID-19 Market Scenario
14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Japan Vaccine Contract Manufacturing Market Analysis
14.12.1 Japan's Takara Bio To Launch Contract Production Of Mrna Vaccines
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 South Korea Vaccine Contract Manufacturing Market Analysis
14.13.1 Moderna, Novavax To Produce More COVID-19 Vaccines In South Korea
14.13.2 South Korea’s SK Bioscience Expands Manufacturing Agreement For Novavax’s COVID-19 Vaccine
14.13.3 Pre-COVID-19 Market Scenario
14.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Australia Vaccine Contract Manufacturing Market Analysis
14.14.1 Novavax Hunts For Australian Manufacturer As CSL Homes In On AstraZeneca Vaccine Production
14.14.2 Australia Plans To Stop AstraZeneca Vaccine Production
14.14.3 Pre-COVID-19 Market Scenario
14.14.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.15 Rest of Asia-Pacific Vaccine Contract Manufacturing Market Analysis
14.15.1 Pre-COVID-19 Market Scenario
14.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 LAMEA Vaccine Contract Manufacturing Market Analysis
15.1 PAHO Welcomes First WHO Emergency Use Listing Of COVID-19 Vaccine Produced In Latin America
15.2 Brazil And Argentina Tapped To Make mRNA Vaccines In Latin America
15.3 LAMEA Market Size Estimation and Forecast
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 Country Market Size Estimation and Forecast
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and Forecast By Process
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast By Downstream
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast By Upstream
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast By Vaccine Type
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 LAMEA Market Size Estimation and Forecast By Company Size
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 LAMEA Market Size Estimation and Forecast By Operation
15.10.1 Pre-COVID-19 Market Scenario
15.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 Brazil Vaccine Contract Manufacturing Market Analysis
15.11.1 Pfizer, Biontech Sign On With Eurofarma Of Brazil For COVID-19 Vaccine Production
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.12 South Africa Vaccine Contract Manufacturing Market Analysis
15.12.1 Janssen And Aspen Enter Deal To Manufacture Covid-19 Vaccine In Africa
15.12.2 Pre-COVID-19 Market Scenario
15.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.13 Saudi Arabia Vaccine Contract Manufacturing Market Analysis
15.13.1 Saudi Arabia Agrees Deal With GSK To Develop Healthcare Sector
15.13.2 Pre-COVID-19 Market Scenario
15.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.14 Turkey Vaccine Contract Manufacturing Market Analysis
15.14.1 Turkey Renews SK Bioscience’s Vaccine Manufacturing Certification
15.14.2 Pre-COVID-19 Market Scenario
15.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.15 UAE Vaccine Contract Manufacturing Market Analysis
15.15.1 Mubadala, G42 To Set Up Biopharma Manufacturing Campus In Abu Dhabi
15.15.2 Pre-COVID-19 Market Scenario
15.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.16 Rest of LAMEA Vaccine Contract Manufacturing Market Analysis
15.16.1 Pre-COVID-19 Market Scenario
15.16.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16 Company Profiles
16.1 Catalent
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product/Service Benchmarking
16.1.5 Company Recent Developments
16.2 Emergent BioSolutions
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product/Service Benchmarking
16.2.5 Company Recent Developments
16.3 GlaxoSmithKline
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product/Service Benchmarking
16.3.5 Company Recent Developments
16.4 Lonza Group AG
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financial Profile
16.4.4 Company Product/Service Benchmarking
16.4.5 Company Recent Developments
16.5 Merck KGaA
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Financial Profile
16.5.4 Company Product/Service Benchmarking
16.5.5 Company Recent Developments
16.6 Pfizer
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Financial Profile
16.6.4 Company Product/Service Benchmarking
16.6.5 Company Recent Developments
16.7 Siegfried Holding
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financial Profile
16.7.4 Company Product/Service Benchmarking
16.7.5 Company Recent Developments
16.8 Sanofi
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Financial Profile
16.8.4 Company Product/Service Benchmarking
16.9 Bavarian Nordic
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financial Profile
16.9.4 Company Product/Service Benchmarking
16.10 FUJIFILM Holdings Corp
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Financial Profile
16.10.1 Company Product/Service Benchmarking
16.11 Charles River Laboratories
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Company Financial Profile
16.11.4 Company Product/Service Benchmarking
16.11.5 Company Recent Developments
16.12 Samsung Biologics
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Company Financial Profile
16.12.4 Company Product/Service Benchmarking
16.12.5 Company Recent Developments
16.13 AbbVie
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Company Financial Profile
16.13.4 Company Product/Service Benchmarking
16.14 Thermo Fisher Scientific Inc
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Company Financial Profile
16.14.4 Company Product/Service Benchmarking
16.14.5 Company Recent Developments
16.15 Eurofins Scientific
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Company Financial Profile
16.15.4 Company Product/Service Benchmarking
16.15.5 Company Recent Developments
16.16 WuXi Biologics
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Company Financial Profile
16.16.4 Company Product/Service Benchmarking
16.16.5 Company Recent Developments
16.17 Serum Institute of India
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Company Product/Service Benchmarking
16.17.4 Company Recent Developments
16.18 Richter-Helm BioLogics
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Company Product/Service Benchmarking
16.18.4 Company Recent Developments
16.19 Wacker Biotech B.V
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Company Product/Service Benchmarking
16.20 Kemwell Biopharma
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Company Product/Service Benchmarking
17 Conclusion
17.1 Concluding Remarks
17.2 Recommendations
List of Tables
Table 1. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 2. Global Vaccine Contract Manufacturing Market Snapshot, 2022 & 2032 (US$million, CAGR %)
Table 3. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 4. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 5. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 6. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 7. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 8. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 9. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 10. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 11. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 12. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 13. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 14. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 15. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 16. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 17. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 18. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 19. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 20. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 21. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 22. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 23. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 24. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 25. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 26. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 27. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 28. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 29. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 30. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 31. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 32. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 33. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 34. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 35. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 36. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 37. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 38. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 39. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 40. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 41. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 42. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 43. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 44. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 45. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 46. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 47. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 48. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 49. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 50. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 51. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 52. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 53. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 54. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 55. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 56. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 57. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 58. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 59. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 60. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 61. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 62. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 63. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 64. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 65. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 66. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 67. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 68. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 69. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 70. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 71. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 72. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 73. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 74. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 75. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 76. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 77. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 78. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 79. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 80. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 81. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 82. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 83. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 84. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 85. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 86. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 87. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 88. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 89. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 90. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 91. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 92. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 93. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 94. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 95. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 96. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 97. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 98. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 99. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 100. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 101. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 102. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 103. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 104. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 105. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 106. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 107. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 108. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 109. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 110. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 111. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 112. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 113. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 114. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 115. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 116. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 117. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 118. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 119. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 120. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 121. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 122. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 123. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 124. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 125. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 126. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 127. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 128. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 129. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 130. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 131. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 132. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 133. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 134. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 135. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 136. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 137. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 138. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 139. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 140. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 141. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 142. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 143. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 144. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 145. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 146. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 147. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 148. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 149. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 150. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 151. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 152. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 153. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 154. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 155. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 156. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 157. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 158. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 159. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 160. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 161. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 162. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 163. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 164. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 165. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 166. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 167. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 168. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 169. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 170. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 171. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 172. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 173. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 174. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 175. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 176. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 177. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 178. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 179. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 180. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 181. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 182. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 183. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 184. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 185. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 186. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 187. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 188. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 189. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 190. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 191. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 192. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 193. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 194. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 195. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 196. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 197. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 198. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 199. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 200. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 201. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 202. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 203. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 204. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 205. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 206. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 207. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 208. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 209. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 210. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 211. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 212. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 213. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 214. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 215. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 216. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 217. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 218. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 219. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 220. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 221. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 222. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 223. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 224. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 225. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 226. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 227. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 228. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 229. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 230. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 231. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 232. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 233. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 234. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 235. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 236. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 237. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 238. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 239. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 240. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 241. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 242. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 243. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 244. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 245. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 246. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 247. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 248. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 249. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 250. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 251. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 252. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 253. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 254. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 255. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 256. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 257. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 258. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 259. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 260. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 261. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 262. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 263. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 264. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 265. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 266. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 267. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 268. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 269. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 270. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 271. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 272. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 273. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 274. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 275. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 276. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 277. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 278. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 279. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 280. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 281. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 282. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 283. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 284. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 285. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 286. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 287. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 288. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 289. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 290. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 291. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 292. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 293. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 294. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 295. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 296. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 297. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 298. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 299. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 300. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 301. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 302. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 303. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 304. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Table 305. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Table 306. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Table 307. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Table 308. Catalent: Company Information
Table 309. Catalent: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 310. Catalent: Company Product and Service Benchmarking
Table 311. Catalent: Company Recent Developments till Feb,2021
Table 312. Emergent BioSolutions: Company Information
Table 313. Emergent BioSolutions: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 314. Emergent BioSolutions: Company Product and Service Benchmarking
Table 315. Emergent BioSolutions: Company Recent Developments
Table 316. GlaxoSmithKline: Company Information
Table 317. GlaxoSmithKline: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 318. GlaxoSmithKline: Company Product and Service Benchmarking
Table 319. GlaxoSmithKline: Company Recent Developments
Table 320. Lonza Group AG: Company Information
Table 321. Lonza Group AG: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 322. Lonza Group AG : Company Product and Service Benchmarking
Table 323. Lonza Group AG: Company Recent Developments till Feb,2021
Table 324. Merck KGaA: Company Information
Table 325. Merck KGaA: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 326. Merck KGaA: Company Product and Service Benchmarking
Table 327. Merck KGaA: Company Recent Developments
Table 328. Pfizer: Company Information
Table 329. Pfizer: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 330. Pfizer: Company Product and Service Benchmarking
Table 331. Pfizer: Company Recent Developments
Table 332. Siegfried Holding: Company Information
Table 333. Siegfried Holding: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 334. Siegfried Holding: Company Product and Service Benchmarking
Table 335. Siegfried Holding: Company Recent Developments till Feb,2021
Table 336. Sanofi: Company Information
Table 337. Sanofi: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 338. Sanofi: Company Product and Service Benchmarking
Table 339. Bavarian Nordic: Company Information
Table 340. Bavarian Nordic: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 341. Bavarian Nordic: Company Product and Service Benchmarking
Table 342. FUJIFILM Holdings Corp: Company Information
Table 343. FUJIFILM Holdings Corp: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 344. FUJIFILM Holdings Corporation : Company Product and Service Benchmarking
Table 345. Charles River Laboratories: Company Information
Table 346. Charles River Laboratories: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 347. Charles River Laboratories: Company Product and Service Benchmarking
Table 348. Charles River Laboratories: Company Recent Developments till Feb,2021
Table 349. Samsung Biologics: Company Information
Table 350. Samsung Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 351. Samsung Biologics: Company Product and Service Benchmarking
Table 352. Samsung Biologics: Company Recent Developments
Table 353. AbbVie: Company Information
Table 354. AbbVie: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 355. AbbVie: Company Product and Service Benchmarking
Table 356. Thermo Fisher Scientific Inc: Company Information
Table 357. Thermo Fisher Scientific Inc: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 358. Thermo Fisher Scientific Inc: Company Product and Service Benchmarking
Table 359. Thermo Fisher Scientific Inc: Company Recent Developments till Feb,2021
Table 360. Eurofins Scientific: Company Information
Table 361. Eurofins Scientific: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 362. Eurofins Scientific: Company Product and Service Benchmarking
Table 363. Eurofins Scientific: Company Recent Developments
Table 364. WuXi Biologics: Company Information
Table 365. WuXi Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 366. WuXi Biologics: Company Product and Service Benchmarking
Table 367. WuXi Biologics: Company Recent Developments till Feb,2021
Table 368. Serum Institute of India: Company Information
Table 369. Serum Institute of India: Company Product and Service Benchmarking
Table 370. Serum Institute of India: Company Recent Developments
Table 371. Richter-Helm BioLogics: Company Information
Table 372. Richter-Helm BioLogics: Company Product and Service Benchmarking
Table 373. Richter-Helm BioLogics: Company Recent Developments
Table 374. Wacker Biotech B.V: Company Information
Table 375. Wacker Biotech B.V: Company Product and Service Benchmarking
Table 376. Kemwell Biopharma: Company Information
Table 377. Kemwell Biopharma: Company Product and Service Benchmarking
List of Figures
Figure 1. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 2. Global Vaccine Contract Manufacturing Market Segmentation
Figure 3. Global Vaccine Contract Manufacturing Market Trends :
Figure 4. Porter’s Five Forces Analysis of Vaccine Contract Manufacturing Market
Figure 5. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 6. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 7. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 8. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 9. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 10. Global Vaccine Contract Manufacturing Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 11. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 12. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery)
Figure 13. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery)
Figure 14. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery)
Figure 15. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery)
Figure 16. Global Vaccine Contract Manufacturing Market Share Forecast by Process 2022, 2027, 2032(%)
Figure 17. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 18. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 19. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 20. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 21. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 22. Global Vaccine Contract Manufacturing Market Share Forecast by Downstream 2022, 2027, 2032(%)
Figure 23. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 24. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 25. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 26. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 27. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 28. Global Vaccine Contract Manufacturing Market Share Forecast by Upstream 2022, 2027, 2032(%)
Figure 29. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 30. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 31. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 32. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 33. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 34. Global Vaccine Contract Manufacturing Market Share Forecast by Vaccine Type 2022, 2027, 2032(%)
Figure 35. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 36. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 37. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 38. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 39. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 40. Global Vaccine Contract Manufacturing Market Share Forecast by Company Size 2022, 2027, 2032(%)
Figure 41. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 42. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 43. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 44. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 45. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 46. Global Vaccine Contract Manufacturing Market Share Forecast by Operation 2022, 2027, 2032(%)
Figure 47. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 48. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 49. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 50. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 51. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 52. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 53. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 54. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 55. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 56. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 57. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 58. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 59. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 60. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 61. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 62. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 63. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 64. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 65. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 66. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 67. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 68. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 69. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 70. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 71. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 72. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 73. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 74. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 75. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 76. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 77. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 78. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 79. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 80. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 81. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 82. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 83. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 84. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 85. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 86. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 87. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 88. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 89. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 90. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 91. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 92. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 93. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 94. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 95. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 96. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 97. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 98. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 99. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 100. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 101. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 102. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 103. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 104. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 105. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 106. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 107. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 108. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 109. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 110. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 111. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 112. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 113. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 114. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 115. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 116. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 117. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 118. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 119. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 120. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 121. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 122. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 123. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 124. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 125. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 126. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 127. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 128. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 129. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 130. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 131. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 132. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 133. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 134. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 135. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 136. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 137. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 138. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 139. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 140. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 141. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 142. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 143. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 144. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 145. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 146. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 147. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 148. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 149. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 150. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 151. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 152. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 153. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 154. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 155. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 156. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 157. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 158. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 159. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 160. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 161. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 162. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 163. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 164. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 165. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 166. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 167. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 168. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 169. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 170. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 171. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 172. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 173. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 174. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 175. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 176. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 177. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 178. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 179. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 180. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 181. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 182. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 183. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 184. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 185. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 186. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 187. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 188. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 189. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 190. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 191. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 192. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 193. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 194. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 195. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 196. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 197. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 198. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 199. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 200. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 201. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 202. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 203. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 204. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 205. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 206. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 207. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 208. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 209. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 210. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 211. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 212. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 213. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 214. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 215. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 216. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 217. China Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 218. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 219. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 220. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 221. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 222. India Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 223. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 224. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 225. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 226. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 227. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 228. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 229. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 230. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 231. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 232. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 233. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 234. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 235. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 236. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 237. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 238. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 239. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 240. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 241. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 242. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 243. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 244. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 245. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 246. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 247. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 248. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 249. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 250. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 251. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 252. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 253. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 254. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 255. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 256. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 257. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 258. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 259. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 260. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 261. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 262. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 263. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 264. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 265. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 266. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 267. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 268. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 269. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 270. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 271. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 272. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 273. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 274. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 275. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 276. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 277. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 278. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 279. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 280. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 281. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 282. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 283. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 284. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 285. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 286. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 287. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 288. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 289. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 290. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 291. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 292. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 293. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 294. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 295. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 296. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 297. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 298. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 299. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 300. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 301. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 302. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 303. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 304. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 305. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 306. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 307. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 308. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 309. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 310. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 311. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 312. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 313. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V – Shaped Recovery)
Figure 314. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W – Shaped Recovery)
Figure 315. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U – Shaped Recovery)
Figure 316. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L – Shaped Recovery)
Figure 317. Catalent: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 318. Catalent: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 319. Catalent: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 320. Catalent: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 321. Emergent BioSolutions: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 322. Emergent BioSolutions: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 323. Emergent BioSolutions: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 324. Emergent BioSolutions: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 325. GlaxoSmithKline: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 326. GlaxoSmithKline: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 327. GlaxoSmithKline: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 328. GlaxoSmithKline: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 329. Lonza Group AG: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 330. Lonza Group AG: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 331. Lonza Group AG: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 332. Lonza Group AG: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 333. Merck KGaA: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 334. Merck KGaA: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 335. Merck KGaA: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 336. Merck KGaA: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 337. Pfizer: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 338. Pfizer: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 339. Pfizer: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 340. Pfizer: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 341. Siegfried Holding: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 342. Siegfried Holding: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 343. Siegfried Holding: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 344. Siegfried Holding: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 345. Sanofi: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 346. Sanofi: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 347. Sanofi: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 348. Sanofi: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 349. Bavarian Nordic: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 350. Bavarian Nordic: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 351. Bavarian Nordic: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 352. Bavarian Nordic: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 353. FUJIFILM Holdings Corp: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 354. FUJIFILM Holdings Corp: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 355. FUJIFILM Holdings Corp: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 356. FUJIFILM Holdings Corp: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 357. Charles River Laboratories: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 358. Charles River Laboratories: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 359. Charles River Laboratories: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 360. Charles River Laboratories: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 361. Samsung Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 362. Samsung Biologics: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 363. Samsung Biologics: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 364. Samsung Biologics: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 365. AbbVie: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 366. AbbVie: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 367. AbbVie: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 368. AbbVie: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 369. Thermo Fisher Scientific Inc: Company Revenue 2017-2021 (US$Mn, AGR %)
Figure 370. Thermo Fisher Scientific Inc: Company Operating Income 2017-2021 (US$Mn, AGR %)
Figure 371. Thermo Fisher Scientific Inc: Company Net Income 2017-2021 (US$Mn, AGR %)
Figure 372. Thermo Fisher Scientific Inc: Company EBITDA 2017-2021 (US$Mn, AGR %)
Figure 373. Eurofins Scientific: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 374. Eurofins Scientific: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 375. Eurofins Scientific: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 376. Eurofins Scientific: Company EBITDA 2016-2020 (US$Mn, AGR %)
Figure 377. WuXi Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Figure 378. WuXi Biologics: Company Operating Income 2016-2020 (US$Mn, AGR %)
Figure 379. WuXi Biologics: Company Net Income 2016-2020 (US$Mn, AGR %)
Figure 380. WuXi Biologics: Company EBITDA 2016-2020 (US$Mn, AGR %)
List of Companies Profiled in the report
AbbVie Inc. (AbbVie)
Bavarian Nordic A/S
Catalent, Inc.
Charles River Laboratories International, Inc.
Emergent BioSolutions Inc.
Eurofins Scientific SE
FUJIFILM Holdings Corporation
GlaxoSmithKline PLC
Kemwell Biopharma
Lonza Group AG (Lonza)
Merck KGaA
Pfizer Inc. (Pfizer)
Richter-Helm BioLogics
Samsung Biologics Co Ltd
Sanofi SA
Serum Institute of India
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Wacker Biotech B.V
WuXi Biologics Cayman Inc
List of Other Companies Mentioned in the report
53Biologics
Alcami
AmbioPharm, Inc.
Avid Bioservices, Inc.
Batavia Biosciences
Baxter BioPharma Solutions
Biodextris Inc.
Biopharma Group
Burrard Pharmaceuticals
Cytovance Biologics
Dalton Pharma Services
Diosynth Biotechnologies
Dyadic International
Emergent CDMO
Evonik
IDT Biologika
Jubilant HollisterStier CMO
KP Pharmaceutical Technology
LSNE Contract Manufacturing
Nitto Avecia Pharma Services
Novasep
Rommelag CMO
Rovi Pharma Industrial Services
Samsung Biologics
Symbiosis
Syngene
Syntegon Pharma Technology
UI Pharmaceuticals
Vetter Pharma International
List of Associations Mentioned in the Report
Biomedical Advanced Research and Development Authority (BARDA)
Center for Disease Control (CDC)
Centers for Disease Control and Prevention
China Food and Drug Administration (CFDA)
Contract Pharma Outsourcing Survey
Defense Advanced Research Projects Agency (DARPA)
Department of Health and Human Services (HHS)
Emory University
European Medical Agency
Food and Drug Administration (FDA)
Global Vaccine Action Plan
Government of Canada
Gulf Cooperation Council Member States
National Institute of Allergy and Infectious Diseases (NIAID)
U.S. Department of Health and Human Services Office
U.S. Department of Homeland Security
United Nations Children's Fund
World Health Assembly
World Health Organisation (WHO)
AbbVie Inc. (AbbVie)
Bavarian Nordic A/S
Catalent, Inc.
Charles River Laboratories International, Inc.
Emergent BioSolutions Inc.
Eurofins Scientific SE
FUJIFILM Holdings Corporation
GlaxoSmithKline PLC
Kemwell Biopharma
Lonza Group AG (Lonza)
Merck KGaA
Pfizer Inc. (Pfizer)
Richter-Helm BioLogics
Samsung Biologics Co Ltd
Sanofi SA
Serum Institute of India
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Wacker Biotech B.V
WuXi Biologics Cayman Inc
List of Other Companies Mentioned in the report
53Biologics
Alcami
AmbioPharm, Inc.
Avid Bioservices, Inc.
Batavia Biosciences
Baxter BioPharma Solutions
Biodextris Inc.
Biopharma Group
Burrard Pharmaceuticals
Cytovance Biologics
Dalton Pharma Services
Diosynth Biotechnologies
Dyadic International
Emergent CDMO
Evonik
IDT Biologika
Jubilant HollisterStier CMO
KP Pharmaceutical Technology
LSNE Contract Manufacturing
Nitto Avecia Pharma Services
Novasep
Rommelag CMO
Rovi Pharma Industrial Services
Samsung Biologics
Symbiosis
Syngene
Syntegon Pharma Technology
UI Pharmaceuticals
Vetter Pharma International
List of Associations Mentioned in the Report
Biomedical Advanced Research and Development Authority (BARDA)
Center for Disease Control (CDC)
Centers for Disease Control and Prevention
China Food and Drug Administration (CFDA)
Contract Pharma Outsourcing Survey
Defense Advanced Research Projects Agency (DARPA)
Department of Health and Human Services (HHS)
Emory University
European Medical Agency
Food and Drug Administration (FDA)
Global Vaccine Action Plan
Government of Canada
Gulf Cooperation Council Member States
National Institute of Allergy and Infectious Diseases (NIAID)
U.S. Department of Health and Human Services Office
U.S. Department of Homeland Security
United Nations Children's Fund
World Health Assembly
World Health Organisation (WHO)
Download sample pages
Complete the form below to download your free sample pages for Vaccine Contract Manufacturing Market Report 2022-2032Related reports
-
Veterinary Vaccines Market Report 2022-2032
The increased frequency of zoonotic illnesses, activities by different government agencies and animal groups to protect animal health, and the...Full DetailsPublished: 28 February 2022 -
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031
Contract manufacturing outsourcing is gaining attraction owing to growing trend of outsourcing among pharmaceutical businesses. ...Full DetailsPublished: 16 November 2021 -
Contract Research Organisations (CROs) Market Report 2022-2032
The global Contract Research Organizations (CROs) market was valued at US$57.1 billion in 2021 and is projected to grow at...Full DetailsPublished: 12 August 2022 -
Pharmaceutical Contract Manufacturing Market Report 2022-2032
The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D,...Full DetailsPublished: 13 April 2022 -
Vaccine Sales Market Report 2022-2032
Rising epidemic potential, a growing emphasis on therapeutic vaccines, and new markets are projected to provide considerable growth prospects for...Full DetailsPublished: 21 April 2022 -
Pharma Contract Sales Market Report 2022-2032
The global pharma contract sales market was valued at US$5,303.0 million in 2021 and is projected to grow at a...Full DetailsPublished: 31 October 2022 -
Pharmaceutical Contract Manufacturing Market Report 2023-2033
The global Pharmaceutical Contract Manufacturing market was valued at US$146.0 billion in 2023 and is projected to grow at a...Full DetailsPublished: 05 April 2023 -
Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry....Full DetailsPublished: 06 January 2021 -
Medical Device Contract Manufacturing Market Report 2022-2032
The medical device contract manufacturing market was valued at US$69.22 billion in 2021 and is projected to grow at a...Full DetailsPublished: 13 September 2022 -
Clinical Trial Imaging Market Report 2023-2033
The global Clinical Trial Imaging market is projected to grow at a CAGR of 7.5% by 2033...Full DetailsPublished: 27 April 2023
Download sample pages
Complete the form below to download your free sample pages for Vaccine Contract Manufacturing Market Report 2022-2032Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
